Insiders · Profile

D.B. ZWIRN & CO., L.P.

See Remarks at IGC Pharma. Filing since 7 Mar 2008. CIK 0001243310

Company
Date
Role
Action
Shares
Amount
Of holding
7 Mar 2008
See Remarks
Sold, plan not stated
1,485,404
$8.82M
100%
1 decision on file.